Royal Bank of Canada Has $10.03 Million Stock Holdings in U.S. Physical Therapy, Inc. $USPH

Royal Bank of Canada boosted its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 22.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 133,777 shares of the company’s stock after purchasing an additional 24,081 shares during the quarter. Royal Bank of Canada owned about 0.88% of U.S. Physical Therapy worth $10,029,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Hantz Financial Services Inc. increased its position in U.S. Physical Therapy by 56.4% during the fourth quarter. Hantz Financial Services Inc. now owns 366 shares of the company’s stock worth $29,000 after acquiring an additional 132 shares during the period. Huntington National Bank lifted its stake in shares of U.S. Physical Therapy by 15.4% in the fourth quarter. Huntington National Bank now owns 1,052 shares of the company’s stock valued at $82,000 after buying an additional 140 shares during the period. Osaic Holdings Inc. lifted its stake in shares of U.S. Physical Therapy by 1.6% in the second quarter. Osaic Holdings Inc. now owns 10,447 shares of the company’s stock valued at $817,000 after buying an additional 166 shares during the period. Snowden Capital Advisors LLC grew its position in U.S. Physical Therapy by 3.6% during the second quarter. Snowden Capital Advisors LLC now owns 5,600 shares of the company’s stock worth $438,000 after buying an additional 195 shares in the last quarter. Finally, Janney Montgomery Scott LLC grew its position in U.S. Physical Therapy by 6.7% during the first quarter. Janney Montgomery Scott LLC now owns 3,381 shares of the company’s stock worth $253,000 after buying an additional 212 shares in the last quarter.

U.S. Physical Therapy Stock Performance

NYSE:USPH opened at $79.89 on Monday. The firm has a market capitalization of $1.22 billion, a PE ratio of 469.97, a price-to-earnings-growth ratio of 2.18 and a beta of 1.13. The company has a quick ratio of 1.19, a current ratio of 1.27 and a debt-to-equity ratio of 0.48. U.S. Physical Therapy, Inc. has a 12-month low of $58.19 and a 12-month high of $93.50. The firm has a 50-day moving average price of $70.17 and a 200 day moving average price of $74.15.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings data on Wednesday, August 5th. The company reported $0.75 earnings per share for the quarter, missing the consensus estimate of $0.81 by ($0.06). The company had revenue of $214.06 million during the quarter, compared to the consensus estimate of $211.36 million. U.S. Physical Therapy had a net margin of 3.97% and a return on equity of 9.39%. The company’s revenue for the quarter was up 8.5% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.81 earnings per share. Research analysts anticipate that U.S. Physical Therapy, Inc. will post 2.98 earnings per share for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, September 11th. Stockholders of record on Friday, August 21st will be issued a $0.46 dividend. The ex-dividend date of this dividend is Friday, August 21st. This represents a $1.84 annualized dividend and a dividend yield of 2.3%. U.S. Physical Therapy’s dividend payout ratio is presently 1,082.35%.

Insider Buying and Selling at U.S. Physical Therapy

In other news, Director Peter Francis Minan bought 492 shares of the company’s stock in a transaction that occurred on Monday, June 8th. The stock was acquired at an average price of $63.14 per share, for a total transaction of $31,064.88. Following the transaction, the director directly owned 2,923 shares of the company’s stock, valued at $184,558.22. This trade represents a 20.24% increase in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Insiders own 2.40% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have commented on USPH shares. Zacks Research raised U.S. Physical Therapy from a “strong sell” rating to a “hold” rating in a report on Wednesday, May 27th. Citizens Jmp reissued a “market outperform” rating and set a $98.00 price objective on shares of U.S. Physical Therapy in a report on Wednesday, June 24th. Barrington Research lowered their price objective on U.S. Physical Therapy from $103.00 to $90.00 and set an “outperform” rating on the stock in a research report on Wednesday, May 13th. Citigroup reaffirmed a “market outperform” rating on shares of U.S. Physical Therapy in a research report on Friday, July 24th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of U.S. Physical Therapy in a research note on Friday, May 29th. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $97.50.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.